Kirk Campbell is a Nephrology physician. ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
One Gustave L.Levy Place
New York, NY 100296574
Telephone
212-987-7208Registry record last updated 10 Jan 2011.
Clinical trials
- Telerehabilitation Following Meniscectomy
Sponsor: NYU Langone Health
- TeleRehabilitation Following Arthroscopic Rotator Cuff Repair
Sponsor: NYU Langone Health
- TeleRehabilitation Following ACL Reconstruction
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202513 payments$24,913openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202511 payments$18,585openpaymentsdata.cms.gov ↗
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Beta blocker100%Carvedilol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 2010–2025 per NIH RePORTER. The latest:
- Plasminogen in glomerular disease progression
Icahn School of Medicine at Mount Sinai
FY2025$859,562R01DK126477 - Mount Sinai Health System Kidney Precision Medicine Project
Icahn School of Medicine at Mount Sinai
FY2025$374,999U01DK133093 - NIH FIRST Cohort Cluster Hiring Initiative at Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
FY2024$5,539,229U54CA267776
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”